| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.004 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.17 | 0.004 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.22 | 0.005 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |